Immunological Changes in Peripheral Blood of Ankylosing Spondylitis Patients during Anti-TNF-α Therapy and Their Correlations with Treatment Outcomes

Tumor necrosis factor-α (TNF-α) inhibitors are the main types of biological conventional synthetic disease-modifying antirheumatic drugs and have efficacy in treating ankylosing spondylitis (AS) which is not sensitive for nonsteroidal anti-inflammatory drug. However, the impact of TNF-α inhibitors o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Rongjuan, Qian, Hongyan, Yuan, Xiaoqing, Chen, Shiju, Liu, Yuan, Wang, Bin, Shi, Guixiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536454/
https://www.ncbi.nlm.nih.gov/pubmed/34692850
http://dx.doi.org/10.1155/2021/1017938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536454/
https://www.ncbi.nlm.nih.gov/pubmed/34692850
http://dx.doi.org/10.1155/2021/1017938

Ejemplares similares